Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
LOTION
**Dosage and Administration:** Desonide (Desowen) Cream 0.05% or Lotion 0.05% should be applied to the affected areas as a thin film two or three times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions or as prescribed by a physician. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
TOPICAL
Medical Information
**Indication:** Desonide (Desowen) Cream 0.05% and Lotion 0.05% are indicated for the relief of the inflammatory and pruritic manifestation of corticosteroid-responsive dermatoses.
**Contraindication:** Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any components of the preparations.
D07AB08
desonide
Manufacturer Information
GALDERMA SINGAPORE PRIVATE LIMITED
LABORATOIRES GALDERMA
Active Ingredients
Documents
Package Inserts
DESOWEN PI.pdf
Approved: September 27, 2019